𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Involvement of fractin in TGF-β-induced apoptosis in oligodendroglial progenitor cells

✍ Scribed by Ramona Schulz; Tanja Vogel; Tetsuo Mashima; Takashi Tsuruo; Kerstin Krieglstein


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
376 KB
Volume
57
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Transforming growth factor‐β (TGF‐β) induces apoptotic cell death during the development of the nervous system. We recently identified that TGF‐β induced apoptosis in oligodendroglial progenitor cells (primary cells as well as oligodendroglial cell line OLI‐neu) is characterized by down‐regulation of Bcl‐xl. In this report, we now focused on mechanisms that mediate TGF‐β dependent Bcl‐xl down‐regulation in oligodendroglial cells. We showed that the caspase‐specific cleavage product Fractin is produced in oligodendroglial cells during TGF‐β‐mediated apoptosis, which represents an early event of the cascade. Cleavage of actin into Fractin was dependent on functional actin and caspases, and occurred simultaneously with a Fractin‐Bcl‐xl‐interaction. This Fractin‐Bcl‐xl interaction indicated a connection between Bcl‐xl down‐regulation and Fractin appearance, since Bcl‐xl regulation was also dependent on caspases and functional actin, and an overexpression of Fractin induced a Bcl‐xl protein down‐regulation. Further analysis of Fractin‐Bcl‐xl interaction in other culture systems confirmed these data. In conclusion, we show that Fractin is not only an apoptotic marker, but has indeed a functional role in apoptotic signaling in oligodendrocytes. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Involvement of Smads in TGFβ1-induced fu
✍ François Blanchette; Penny Rudd; Francine Grondin; Liliana Attisano; Claire M. D 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

## Abstract Furin is recognized as being one of the main convertases of the cellular constitutive secretion pathway but the mechanisms regulating its expression are still unknown. We have previously demonstrated that TGFβ1 up‐regulates its own converting enzyme, furin, creating a novel activation/r

Involvement of p53 in oroxylin A-induced
✍ Rong Mu; Qi Qi; Hongyan Gu; Jia Wang; Yong Yang; Jingjing Rong; Wei Liu; Na Lu; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB

## Abstract Oroxylin A, a naturally occurring monoflavonoid extracted from __Scutellariae__ radix, exhibits anticancer activity and induces apoptosis in human hepatocellular carcinoma HepG2 cells according to our previous data. In this study, we investigate whether p53 is involved in oroxylin A‐tri

Protection of 5α-dihydrotestosterone aga
✍ In Kyoung Lim; Hee Jae Joo; Kyeong Sook Choi; Eisaburo Sueoka; Myung Soog Lee; M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 329 KB 👁 1 views

Administration of TGF-b1 to both FaO and HepG 2 cells significantly induced apoptosis, particularly in FaO cells. Degradation of genomic DNA in FaO cells was rapidly induced by treatment with TGF-b1 (5 ng/ml) for only 4 hr. 5a-dihydrotestosterone (DHT, 25 nM) alone did not affect any significant cha

A TGF-β-inducible cell adhesion molecule
✍ Jung-Eun Kim; Eui-Hyun Kim; Eun-Hee Han; Rang-Woon Park; Il-Hyung Park; Soo-Han 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

Melorheostosis is a rare bone disease characterized by linear hyperostosis and associated soft tissue abnormalities. The skin overlying the involved bone lesion is often tense, shiny, erythematous, and scleodermatous. In order to look for genes differentially expressed between the normal and involve

Involvement of p38 MAP kinase in TGF-β-s
✍ Takuji Yamamoto; Osamu Kozawa; Kumiko Tanabe; Shigeru Akamatsu; Hiroyuki Matsuno 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

## Abstract Although it is known that transforming growth factor (TGF)‐β induces vascular endothelial growth factor (VEGF) synthesis in vascular smooth muscle cells, the underlying mechanisms are still poorly understood. In the present study, we examined whether the mitogen‐activated protein (MAP)